New asthma guidelines emphasize control, regular monitoring

被引:11
作者
Lang, David M. [1 ]
机构
[1] Cleveland Clin, Resp Inst, Sect Allergy Immunol, Asthma Ctr, Cleveland, OH 44195 USA
关键词
D O I
10.3949/ccjm.75.9.641
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Updated asthma care guidelines have recently been released. This review will focus on several elements in the third Expert Panel Report (EPR3) guidelines that reflect substantial differences from recommendations of the second EPR (EPR2) guidelines, issued in 1997 and updated in 2002. A major difference is the emphasis on asthma control. Asthma control can be assessed serially by the use of validated instruments. The goal of asthma therapy is to achieve asthma control by reducing current impairment and future risk. Recommendations for asthma pharmacotherapy have also been revised since the release of the updated EPR2 guidelines. The revisions in asthma management proposed in these guidelines offer the potential for improved asthma care outcomes in the United States.
引用
收藏
页码:641 / 653
页数:13
相关论文
共 70 条
[1]  
Abramson MJ, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001186, DOI 10.1002/14651858.CD001186]
[2]   Mechanisms of allergen-specific immunotherapy [J].
Akdis, Muebeccel ;
Akdis, Cezmi A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (04) :780-789
[3]   Bronchodilator treatment and deaths from asthma: case-control study [J].
Anderson, HR ;
Ayres, JG ;
Sturdy, PM ;
Bland, JM ;
Butland, BK ;
Peckitt, C ;
Taylor, JC ;
Victor, CR .
BRITISH MEDICAL JOURNAL, 2005, 330 (7483) :117-120
[4]   Allergen specific immunotherapy attenuates early and late phase reactions in lower airways of birch pollen asthmatic patients:: a double blind placebo-controlled study [J].
Arvidsson, MB ;
Löwhagen, O ;
Rak, S .
ALLERGY, 2004, 59 (01) :74-80
[5]   Can guideline-defined asthma control be achieved? The gaining optimal asthma control study [J].
Bateman, ED ;
Boushey, HA ;
Bousquet, J ;
Busse, WW ;
Clark, TJH ;
Pauwels, RA ;
Pedersen, SE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (08) :836-844
[6]   Allergy diagnostic testing: An updated practice parameter [J].
Bernstein, I. Leonard ;
Li, James T. ;
Bernstein, David I. ;
Hamilton, Robert ;
Spector, Sheldon L. ;
Tan, Ricardo ;
Sicherer, Scott ;
Golden, David B. K. ;
Khan, David A. ;
Nicklas, Richard A. ;
Portnoy, Jay M. ;
Blessing-Moore, Joann ;
Cox, Linda ;
Lang, David M. ;
Oppenheimer, John ;
Randolph, Christopher C. ;
Schuller, Diane E. ;
Tilles, Stephen A. ;
Wallace, Dana V. ;
Levetin, Estelle ;
Weber, Richard .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (03) :S1-S148
[7]   Effect of ADRB2 polymorphisms on response to longacting β2-agonist therapy:: a pharmacogenetic analysis of two randomised studies [J].
Bleecker, Eugene R. ;
Postma, Dirkje S. ;
Lawrance, Rachael M. ;
Meyers, Deborah A. ;
Ambrose, Helen J. ;
Goldman, Mitch .
LANCET, 2007, 370 (9605) :2118-2125
[8]   Salmeterol response is not affected by β2-adrenergic receptor genotype in subjects with persistent asthma [J].
Bleecker, Eugene R. ;
Yancey, Steven W. ;
Baitinger, Leslie A. ;
Edwards, Lisa D. ;
Klotsman, Michael ;
Anderson, Wayne H. ;
Dorinsky, Paul M. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (04) :809-816
[9]   Documenting asthma severity: Do we get it right? [J].
Braganza, S ;
Sharif, I ;
Ozuah, PO .
JOURNAL OF ASTHMA, 2003, 40 (06) :661-665
[10]   Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma [J].
Busse, W ;
Corren, J ;
Lanier, BQ ;
McAlary, M ;
Fowler-Taylor, A ;
Della Cioppa, G ;
van As, A ;
Gupta, N .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (02) :184-190